Management
In this section you will find Management market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
-
OTC Pharmaceuticals - Global Group of Eight (G8) Industry Guide
$1,495.00Published by Datamonitor on Nov 1st, 2010Datamonitor’s OTC Pharmaceuticals - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry in each of the G8... Learn More -
Pharmaceutical Product Lifecycle Management 2010-2020
$2,461.00Published by Visiongain on Jul 6th, 2010where will the greatest challenges and opportunities lie this decade, and what does the future hold? The pharmaceutical industry currently faces marked challenges in its long-standing business model. Product... Learn More -
Biotech Exit Strategies: Delivering value to investors in a challenging funding market
$3,835.00Published by Business Insights on Jun 22nd, 2009Establishing the most effective route to exit for a biotech venture is critical in ensuring value is maximized for key stakeholders and the associated technology. However, more critical than selection of exit strategy is the planning and effective execution of exit. Learn More -
Accelerating Lead Generation: Emerging technologies and strategies
$3,835.00Published by Business Insights on Jun 1st, 2009The number of approvals for new drugs and biologics has fallen steadily in recent years, despite increasing R&D expenditure. Improvements to the lead generation process are a key initiative for company’s aiming to avoid expensive compound failures in the latter stages of the drug discovery process. Learn More -
New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
$5,700.00Published by Datamonitor on May 19th, 2009With industry consolidation, the economic downturn, and an increasing threat from generics, pharma companies are coming under greater pressure to fill their pipelines with innovative drugs. Learn More -
Stakeholder Opinions: Diabetic Renal Disease
$3,800.00Published by Datamonitor on Nov 5th, 2008In-depth analysis on the latest challenges, trends and developments in diagnosis, pharmacological and non- pharmacological treatment of Diabetic Renal Disease. Learn More -
Product Lifecycle Management, 2006
$2,418.00Published by Visiongain on May 18th, 2006The global pharmaceutical market with sales of approximately $550 billion is about to enter a pivotal period in its history. The industry has been used to double digit growth rates but growth has now dropped to below 10% for the first time... Learn More -
Personalizing Disease Management Through Technology Solutions: Part II - Vendor Landscape
$3,800.00Published by Datamonitor on Mar 29th, 2006Disease management is not a new concept in the healthcare industry and despite the heterogeneity that characterizes this field, such programs are becoming an important part of the healthcare sector. Learn More -
Personalizing Disease Management through Technology Solutions: Part I
$3,800.00Published by Datamonitor on Mar 15th, 2006Disease management (DM) is becoming an important topic not only within the US health care agenda, but also globally. Forces driving the disease management market include a world-wide aging population and increasing healthcare costs. Additionally, because ROI studies on DM programs have been limited or inconclusive these programs have failed to gain significant traction. Learn More -
Maximizing eHealth Tools for Caregivers: Cultivating Long-Term Relationships
$3,800.00Published by Datamonitor on Feb 7th, 2006Caregivers are taking a more proactive role in providing healthcare to themselves and others, using online tools and services to find information, and influencing physician prescribing decisions by requesting particular medication or discussing specific products. By providing online resources for caregivers, pharma companies can increase brand loyalty among caregivers, and potentially, physicians. Learn More -
The Changing Patient-Physician Relationship Part 2: the Physicians Perspective
$3,800.00Published by Datamonitor on Jan 27th, 2006The Internet has played a key role in changing the patient-physician relationship. Time constrains and productivity pressures are driving physicians to the Internet to keep abreast of medical knowledge. At the same time, physicians are becoming accustomed to the role of patients as consumers. Physician behavior is changing in response to this consumerism trend in healthcare. Learn More -
Pharmacovigilance: A New Era of Drug Safety
$7,600.00Published by Datamonitor on Dec 19th, 2005A series of high profile safety concerns, such as the withdrawal of Vioxx (rofecoxib) and the link between antidepressants and suicidal thoughts in children over the last two years has made drug safety a major issue for governments, regulatory authorities and the pharma industry. This has triggered a period of change across the board, and the industry is now entering a new era of drug safety. Learn More -
eHealth During the Clinical Trial Process - Trends in Study Participation and Clinical Trial Website Usage
$3,800.00Published by Datamonitor on Dec 2nd, 2005Inefficient patient recruitment slows the progress of many clinical trials. Online recruitment has the potential to alleviate some of the current delays. However, the success of this approach depends upon consumers` comfort levels with the clinical trial process. Consumers need more educational resources, such as websites dedicated to providing clinical trial information. Learn More -
Customer Relationship Strategies in Medical Device Industry - Role of CRM and Knowledge Management
$4,163.00Published by HBS Consulting on Dec 1st, 2005The healthcare finance crisis globally has important ramifications for medical technology companies. Learn More -
Lifecycle Management: Accessing New Patient Populations - Maximizing Return on Investment of Indication Management
$11,400.00Published by Datamonitor on Oct 3rd, 2005Successfully managing the lifecycle of molecules within marketed portfolios is an essential capability for the pharma industry. With R&D productivity stalling, and profit margins increasingly eroded by cost containment initiatives, maximizing the return on investment of in-line brands, by extending their use to new patient populations, is a key objective for pharmaceutical companies. Learn More
Management
In this section you will find Management market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
-
OTC Pharmaceuticals - Global Group of Eight (G8) Industry Guide
$1,495.00Published by Datamonitor on Nov 1st, 2010Datamonitor’s OTC Pharmaceuticals - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry in each of the G8... Learn More -
Pharmaceutical Product Lifecycle Management 2010-2020
$2,461.00Published by Visiongain on Jul 6th, 2010where will the greatest challenges and opportunities lie this decade, and what does the future hold? The pharmaceutical industry currently faces marked challenges in its long-standing business model. Product... Learn More -
Biotech Exit Strategies: Delivering value to investors in a challenging funding market
$3,835.00Published by Business Insights on Jun 22nd, 2009Establishing the most effective route to exit for a biotech venture is critical in ensuring value is maximized for key stakeholders and the associated technology. However, more critical than selection of exit strategy is the planning and effective execution of exit. Learn More -
Accelerating Lead Generation: Emerging technologies and strategies
$3,835.00Published by Business Insights on Jun 1st, 2009The number of approvals for new drugs and biologics has fallen steadily in recent years, despite increasing R&D expenditure. Improvements to the lead generation process are a key initiative for company’s aiming to avoid expensive compound failures in the latter stages of the drug discovery process. Learn More -
New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
$5,700.00Published by Datamonitor on May 19th, 2009With industry consolidation, the economic downturn, and an increasing threat from generics, pharma companies are coming under greater pressure to fill their pipelines with innovative drugs. Learn More -
Stakeholder Opinions: Diabetic Renal Disease
$3,800.00Published by Datamonitor on Nov 5th, 2008In-depth analysis on the latest challenges, trends and developments in diagnosis, pharmacological and non- pharmacological treatment of Diabetic Renal Disease. Learn More -
Product Lifecycle Management, 2006
$2,418.00Published by Visiongain on May 18th, 2006The global pharmaceutical market with sales of approximately $550 billion is about to enter a pivotal period in its history. The industry has been used to double digit growth rates but growth has now dropped to below 10% for the first time... Learn More -
Personalizing Disease Management Through Technology Solutions: Part II - Vendor Landscape
$3,800.00Published by Datamonitor on Mar 29th, 2006Disease management is not a new concept in the healthcare industry and despite the heterogeneity that characterizes this field, such programs are becoming an important part of the healthcare sector. Learn More -
Personalizing Disease Management through Technology Solutions: Part I
$3,800.00Published by Datamonitor on Mar 15th, 2006Disease management (DM) is becoming an important topic not only within the US health care agenda, but also globally. Forces driving the disease management market include a world-wide aging population and increasing healthcare costs. Additionally, because ROI studies on DM programs have been limited or inconclusive these programs have failed to gain significant traction. Learn More -
Maximizing eHealth Tools for Caregivers: Cultivating Long-Term Relationships
$3,800.00Published by Datamonitor on Feb 7th, 2006Caregivers are taking a more proactive role in providing healthcare to themselves and others, using online tools and services to find information, and influencing physician prescribing decisions by requesting particular medication or discussing specific products. By providing online resources for caregivers, pharma companies can increase brand loyalty among caregivers, and potentially, physicians. Learn More -
The Changing Patient-Physician Relationship Part 2: the Physicians Perspective
$3,800.00Published by Datamonitor on Jan 27th, 2006The Internet has played a key role in changing the patient-physician relationship. Time constrains and productivity pressures are driving physicians to the Internet to keep abreast of medical knowledge. At the same time, physicians are becoming accustomed to the role of patients as consumers. Physician behavior is changing in response to this consumerism trend in healthcare. Learn More -
Pharmacovigilance: A New Era of Drug Safety
$7,600.00Published by Datamonitor on Dec 19th, 2005A series of high profile safety concerns, such as the withdrawal of Vioxx (rofecoxib) and the link between antidepressants and suicidal thoughts in children over the last two years has made drug safety a major issue for governments, regulatory authorities and the pharma industry. This has triggered a period of change across the board, and the industry is now entering a new era of drug safety. Learn More -
eHealth During the Clinical Trial Process - Trends in Study Participation and Clinical Trial Website Usage
$3,800.00Published by Datamonitor on Dec 2nd, 2005Inefficient patient recruitment slows the progress of many clinical trials. Online recruitment has the potential to alleviate some of the current delays. However, the success of this approach depends upon consumers` comfort levels with the clinical trial process. Consumers need more educational resources, such as websites dedicated to providing clinical trial information. Learn More -
Customer Relationship Strategies in Medical Device Industry - Role of CRM and Knowledge Management
$4,163.00Published by HBS Consulting on Dec 1st, 2005The healthcare finance crisis globally has important ramifications for medical technology companies. Learn More -
Lifecycle Management: Accessing New Patient Populations - Maximizing Return on Investment of Indication Management
$11,400.00Published by Datamonitor on Oct 3rd, 2005Successfully managing the lifecycle of molecules within marketed portfolios is an essential capability for the pharma industry. With R&D productivity stalling, and profit margins increasingly eroded by cost containment initiatives, maximizing the return on investment of in-line brands, by extending their use to new patient populations, is a key objective for pharmaceutical companies. Learn More